Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Thorax

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thorax.57.9.799PMID 12200525PMCID PMC1746422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the management of chronic obstructive pulmonary disease.

  2002cited by this paper
• The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.

  2002cited by this paper
• Global initiative for chronic obstructive lung disease.

  2002cited by this paper
• Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease.

  2001cited by this paper
• Remodeling in asthma and chronic obstructive lung disease.

  2001cited by this paper
• Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease.

  2000cited by this paper
• Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease.

  2000cited by this paper
• LONG-TERM TREATMENT WITH INHALED BUDESONIDE IN PERSONS WITH MILD CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHO CONTINUE SMOKING

  2000cited by this paper
• Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

  2000cited by this paper
• Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease.

  2000cited by this paper
• Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease.

  2000cited by this paper
• Chronic Obstructive Pulmonary Disease: Pathogenesis to Treatment

  2000cited by this paper
• Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

  1999cited by this paper
• Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis

  1999cited by this paper
• CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease.

  1999cited by this paper
• CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.

  1998cited by this paper
• Cytolysis and piecemeal degranulation as distinct modes of activation of airway mucosal eosinophils.

  1998cited by this paper
• Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

  1998cited by this paper
• Myofibroblast involvement in the allergen-induced late response in mild atopic asthma.

  1997cited by this paper
• Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.

  1997cited by this paper
• Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids.

  1997cited by this paper
• Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.

  1997cited by this paper
• BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease

  1997cited by this paper
• Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes.

  1996cited by this paper
• Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

  1996cited by this paper
• Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

  1995cited by this paper
• Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes.

  1995cited by this paper
• Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis.

  1994cited by this paper
• Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines.

  1994cited by this paper
• European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design.

  1992cited by this paper
• Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study.

  1992cited by this paper
• Role of mast cell and neutrophil proteases in airway secretion.

  1991cited by this paper
• Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.

  1990cited by this paper
• Mast cell chymase. A potent secretagogue for airway gland serous cells.

  1989cited by this paper
• Intra-epithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency.

  1982cited by this paper

• How inhaled corticosteroids target inflammation in COPD

  2023cites this paper
• Inhaled corticosteroids versus placebo  for stable chronic obstructive pulmonary disease.

  2023cites this paper
• Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease

  2022cites this paper
• Current opportunities of inhaled corticosteroid therapy in patients with chronic obstructive pulmonary disease

  2021cites this paper
• Involvement of Vascular Endothelial Growth Factor in schizophrenia.

  2021cites this paper
• Pro-and anti-inflammatory effects of glucocorticoid Fluticasone on ovarian and immune functions in commercial-aged laying hens

  2021cites this paper
• Impact on survival of combination inhalers in patients with COPD at high risk of cardiovascular events.

  2019cites this paper
• Chapter 4 Inhaled steroid cessation in stable COPD increases sputum eosinophils and deteriorates lung function

  2018cites this paper
• Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function

  2018cites this paper
• University of Birmingham Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function

  2018cites this paper
• Prevention of copd exacerbations. Focus on dual bronchodilators

  2018cites this paper
• University of Birmingham Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function

  2018cites this paper
• Профилактика обострений хронической обструктивной болезни легких. В фокусе – двойные комбинации бронхолитиков

  2018cites this paper
• Inhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study

  2017cites this paper
• Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis

  2017cites this paper
• Effects Of COPD And Its Treatment On Cardiovascular Structure And Function Assessed Through Advanced Imaging Techniques

  2016cites this paper
• Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Design.

  2016cites this paper
• Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation

  2015cites this paper
• Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment

  2015cites this paper
• Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

  2014cites this paper
• Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.

  2014cites this paper
• Theirs but to die and do: primary lysis of eosinophils and free eosinophil granules in asthma.

  2014cites this paper
• Steroid Resistance in COPD? Overlap and Differential Anti-Inflammatory Effects in Smokers and Ex-Smokers

  2014cites this paper
• Glucocorticoids induce the production of the chemoattractant CCL20 in airway epithelium

  2014cites this paper
• Fabrication of Homogeneous High-Density Antibody Microarrays for Cytokine Detection

  2014cites this paper
• Inhaled corticosteroids in COPD: pros and cons.

  2013cites this paper
• Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go?

  2013cites this paper
• A challenge to the seven widely believed concepts of COPD

  2013cites this paper
• Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease

  2013cites this paper
• Changes in Airway Histone Deacetylase2 in Smokers and COPD with Inhaled Corticosteroids: A Randomized Controlled Trial

  2013cites this paper
• Effectiveness of Inhaled Steroids in the Management of Chronic Obstructive Pulmonary Disease

  2013cites this paper
• Evaluation of Inhaled Corticosteroid Efficacy by Electron Microscopy in Patients with Chronic Obstructive Pulmonary Disease

  2013cites this paper
• Treatment and Outcome

  2012cites this paper
• Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis

  2012cites this paper
• Abrupt withdrawal of inhaled corticosteroids does not result in spirometric deterioration in chronic obstructive pulmonary disease: Effect of phenotyping?

  2012cites this paper
• Lung CD57+ cell density is increased in very severe COPD.

  2012cites this paper
• Is there a Role for Inhaled Corticosteroids and Macrolide Therapy in Bronchiectasis?

  2012cites this paper
• Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?

  2012cites this paper
• Long-acting β2 agonists and corticosteroids restore the reduction of histone deacetylase activity and inhibit H2O2-induced mediator release from alveolar macrophages.

  2012cites this paper
• RECOMENDACIONES PARA LA PREVENCIóN, DIAGNóSTICO y TRATAMIENTO DE LA EPOC EN LA ARGENTINA

  2012cites this paper
• Chronic Obstructive Pulmonary Disease Outcome Measurements

  2012cites this paper
• Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

  2012cites this paper
• [Measurement of bronchoconstrictive eicosanoids in chronic obstructive pulmonary disease].

  2012cites this paper
• Inhaled Salmeterol/Fluticasone Propionate

  2012cites this paper
• [Guidelines for COPD prevention, diagnosis and treatment in Argentina].

  2012cites this paper
• Impact on clinical decision making of quality control standards applied to sputum analysis in COPD.

  2011cites this paper
• Inhibition of granulocyte migration by tiotropium bromide

  2011cites this paper
• PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.

  2011cites this paper
• Rapid Fall in Lung Density Following Smoking Cessation in COPD

  2011cites this paper
• Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease.

  2011cites this paper
• ReviewResolution of cell-mediated airways diseases

  2010influential citation
• Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease

  2010cites this paper
• Transepithelial exit of leucocytes: inflicting, reflecting or resolving airway inflammation?

  2010cites this paper
• The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease

  2010cites this paper
• The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD

  2010cites this paper
• Resolution of cell-mediated airways diseases

  2010influential citation
• Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS.

  2010cites this paper
• Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD).

  2010cites this paper
• Pneumocystis Colonization and Chronic Obstructive Pulmonary Disease in a Simian Model of HIV Infection

  2010cites this paper
• Airway pathology in COPD : smoking cessation and pharmacological treatment intervention. Results from the GLUCOLD study

  2010influential citation
• Langdurige behandeling met inhalatiesteroïden heeft gunstig effect bij matig ernstige COPD

  2010cites this paper
• Reviewof cell-mediated airways diseases

  2010cites this paper
• Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.

  2010cites this paper
• Inhaled corticosteroids in chronic obstructive pulmonary disease: a review

  2010cites this paper
• Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD

  2009cites this paper
• The Effect of Inhaled Corticosteroids on the Development of Emphysema in Smokers Assessed by Annual Computed Tomography

  2009cites this paper
• Inhaled Steroids and Risk of Community-Acquired Pneumonia

  2009cites this paper
• : Bronchial vascular remodelling in COPD patients and its relationship with inhaled steroid treatment

  2009cites this paper
• COPD exacerbations : treatment and outcome

  2009cites this paper
• Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future

  2009cites this paper
• Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.

  2009cites this paper
• Is There a Role for Antiinflammatory Treatment in COPD?

  2009cites this paper
• Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment

  2009cites this paper
• Inflammation in chronic obstructive pulmonary disease : its assessment and the effects of corticosteroids

  2008cites this paper
• Association of mast cells with lung function in chronic obstructive pulmonary disease

  2008cites this paper
• Clinical implications of acute exacerbations in COPD

  2008cites this paper
• Inhaled corticosteroids in COPD: systemic effects of a local therapy?

  2008cites this paper
• p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation

  2008cites this paper
• β2-Agonists Potentiate Corticosteroid-Induced Neutrophil Survival

  2008cites this paper
• A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids

  2008cites this paper
• Inhaled corticosteroids in chronic obstructive pulmonary disease.

  2007cites this paper
• Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease.

  2007cites this paper
• A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.

  2007cites this paper
• p 38 α Selective MAP kinase inhibitor , SD-282 , reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation

  2007cites this paper
• Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

  2007cites this paper
• What have we learned from large drug treatment trials in COPD?

  2007cites this paper
• Female sexual dysfunction in hypopituitarism.

  2007cites this paper
• Investigating outbreaks

  2007cites this paper
• COPD exacerbations, inflammation and treatment

  2007cites this paper
• Agonistas adrenérgicos β2 y corticoides

  2007cites this paper
• Comparison and optimal use of fixed combinations in the management of COPD

  2007cites this paper
• Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

  2007cites this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD

  2007cites this paper
• Inflammatory cell microlocalisation and airway dysfunction: cause and effect?

  2007cites this paper
• Reducing inflammation in COPD: the evidence builds

  2007cites this paper
• The PDE4 inhibitor roflumilast reduces sputum neutrophil and eosinophil numbers in patients with COPD

  2007cites this paper
• Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies.

  2007cites this paper
• Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

  2007cites this paper
• Roflumilast for the treatment of chronic obstructive pulmonary disease.

  2006cites this paper
• Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice

  2006cites this paper